Delivery Order SPE2DB22D3501-SPE2DB25FWB10
Award Date
6/16/25
Potential Completion Date
7/9/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,116.87 firm fixed-price contract is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides global pharmaceutical support to military healthcare programs. The...
This federal contract award, valued at $23,537.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for the supply of IMBRUVICA 140 MG CAPSULE 90S. The total ceiling value of the contract is $47,074.32 with a performance period through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA to provide pharmaceutical products and medical supplies to...
This federal contract award, valued at $8,116.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product, with a completion date of January 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,233.74, is for the delivery of IMBRUVICA 140 MG CAPSULES. It is a Firm Fixed Price Delivery Order contract with a completion date of February 27, 2025. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract, valued at $23,537.16, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of IMBRUVICA 140 MG CAPSULE 90S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
The federal contract award, valued at $7,575.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for IMBRUVICA 420 MG TABLET 28S, with an ultimate completion date of March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a $8,116.87 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IMBRUVICA 140 mg capsules, a specialty medication used to treat certain types of blood cancers. The contract has a period of performance through January 28, 2025 and is not designated as a set-aside procurement. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $7,845.72 firm-fixed-price delivery order is for the supply of IMBRUVICA 140 mg capsules under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA. This single-award IDC serves as the primary vehicle for Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a total ceiling value of $7,120.23 and an ultimate completion date of October 4, 2024. This award is not set-aside and is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...